PB

Peter Bisgaard

Managing Director at NF Life Sciences

San Francisco Bay Area

Overview

Work Experience

PL

Pivotal Life Sciences

  • Managing Director

    2017 - Current

NF Life Sciences

  • Managing Director

    2017

N

Novo

  • Senior Partner

    2001 - 2017

McKinsey & Co.

  • Consultant

    1998 - 2001

Education

Investments

Engrail Therapeutics

Series A

Total Funding: $220M

Oculis

Series B

Total Funding: $190M

Eargo

Series C

Total Funding: $220M

OncXerna Therapeutics

Series B

Total Funding: $80M

Relevant Websites